By Edward Winnick
SAN FRANCISCO (GenomeWeb News) – Austin, Texas-based molecular diagnostics and multiplex instruments firm Luminex on Wednesday presented its plans to enter the newborn screening market over the next couple of years.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.
Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.
Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.
Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.